RegeneRx Biopharmaceuticals, Inc. (RGRX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Oct 29, 2025, 4:00 PM EDT
RGRX Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2013 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2013 - 2017 |
Cash & Equivalents | 0.1 | 0.29 | 1.23 | 0.43 | 0.64 | 0.24 | Upgrade |
Cash & Short-Term Investments | 0.1 | 0.29 | 1.23 | 0.43 | 0.64 | 0.24 | Upgrade |
Cash Growth | -89.02% | -76.38% | 187.83% | -33.13% | 169.71% | 30.57% | Upgrade |
Prepaid Expenses | 0.02 | 0.01 | 0.01 | 0.04 | 0.03 | 0.01 | Upgrade |
Other Current Assets | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | Upgrade |
Total Current Assets | 0.12 | 0.31 | 1.25 | 0.48 | 0.68 | 0.27 | Upgrade |
Property, Plant & Equipment | 0.06 | 0.07 | 0.03 | 0.07 | 0.02 | 0 | Upgrade |
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade |
Total Assets | 0.19 | 0.38 | 1.28 | 0.55 | 0.71 | 0.28 | Upgrade |
Accounts Payable | 0.04 | 0.06 | 0.06 | 0.04 | 0.04 | 0.09 | Upgrade |
Accrued Expenses | 0.47 | 0.37 | 0.26 | 0.21 | 0.1 | 0.09 | Upgrade |
Current Portion of Long-Term Debt | 1.17 | - | - | 0.03 | - | 0.05 | Upgrade |
Current Portion of Leases | 0.05 | 0.04 | 0.03 | 0.04 | 0.03 | - | Upgrade |
Current Unearned Revenue | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade |
Total Current Liabilities | 1.8 | 0.55 | 0.43 | 0.4 | 0.24 | 0.32 | Upgrade |
Long-Term Debt | 0.26 | 1.37 | 1.14 | 0.92 | 0.71 | - | Upgrade |
Long-Term Leases | 0.02 | 0.03 | - | 0.03 | - | - | Upgrade |
Long-Term Unearned Revenue | 1.85 | 1.87 | 1.95 | 2.02 | 2.1 | 2.18 | Upgrade |
Total Liabilities | 3.93 | 3.83 | 3.51 | 3.38 | 3.05 | 2.49 | Upgrade |
Common Stock | 0.14 | 0.14 | 0.14 | 0.13 | 0.13 | 0.13 | Upgrade |
Additional Paid-In Capital | 108.71 | 108.63 | 108.12 | 105.93 | 104.9 | 103.54 | Upgrade |
Retained Earnings | -112.6 | -112.22 | -110.49 | -108.89 | -107.37 | -105.88 | Upgrade |
Shareholders' Equity | -3.74 | -3.45 | -2.23 | -2.82 | -2.34 | -2.21 | Upgrade |
Total Liabilities & Equity | 0.19 | 0.38 | 1.28 | 0.55 | 0.71 | 0.28 | Upgrade |
Total Debt | 1.49 | 1.45 | 1.16 | 1.03 | 0.74 | 0.05 | Upgrade |
Net Cash (Debt) | -1.39 | -1.16 | 0.07 | -0.6 | -0.1 | 0.18 | Upgrade |
Net Cash Per Share | -0.97 | -0.80 | 0.05 | -0.45 | -0.07 | 0.15 | Upgrade |
Filing Date Shares Outstanding | 1.44 | 1.44 | 1.44 | 1.34 | 1.33 | 1.3 | Upgrade |
Total Common Shares Outstanding | 1.44 | 1.44 | 1.44 | 1.33 | 1.32 | 1.28 | Upgrade |
Working Capital | -1.68 | -0.25 | 0.82 | 0.08 | 0.44 | -0.04 | Upgrade |
Book Value Per Share | -2.61 | -2.40 | -1.55 | -2.12 | -1.78 | -1.72 | Upgrade |
Tangible Book Value | -3.74 | -3.45 | -2.23 | -2.82 | -2.34 | -2.21 | Upgrade |
Tangible Book Value Per Share | -2.61 | -2.40 | -1.55 | -2.12 | -1.78 | -1.72 | Upgrade |
Machinery | - | - | - | - | - | 0.1 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.